AstraZeneca has outlined plans to…
AstraZeneca has outlined plans to invest $15 billion in China [...]
A brain tumor has prompted the FDA…
A brain tumor has prompted the FDA to put clinical [...]
CalciMedica’s stock nosedived…
CalciMedica’s stock nosedived after the biotech abandoned a phase 2 [...]
Boehringer Ingelheim has shared…
Boehringer Ingelheim has shared more phase 2 data on its [...]
The FDA is freeing Intellia’s…
The FDA is freeing Intellia’s CRISPR therapy from one of [...]
Ahead of its acquisition by cancer…
Ahead of its acquisition by cancer imaging company Kuva Labs, [...]
Four years after listing on the…
Four years after listing on the Nasdaq, Genenta Sciences is [...]
What do you get when you insert a…
What do you get when you insert a molecular glue [...]
Former CytoDyn CEO Nader…
Former CytoDyn CEO Nader Pourhassan, Ph.D., has received a 30-month [...]
AstraZeneca is showing no signs of…
AstraZeneca is showing no signs of restarting a 200 million [...]